Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.96
(0.51%)
CAD 1.96
(0.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.78 Million CAD | 40.83% |
| 2022 | -50.33 Million CAD | -10.7% |
| 2021 | -45.47 Million CAD | -120.67% |
| 2020 | -20.6 Million CAD | -51.7% |
| 2019 | -13.58 Million CAD | -81.27% |
| 2018 | -7.49 Million CAD | -369.7% |
| 2017 | -1.59 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -7.74 Million CAD | 7.9% |
| 2024 Q1 | -8.4 Million CAD | -4.69% |
| 2023 Q4 | -8.02 Million CAD | 7.89% |
| 2023 FY | -29.78 Million CAD | 40.83% |
| 2023 Q3 | -8.71 Million CAD | -88.3% |
| 2023 Q2 | -4.62 Million CAD | 41.68% |
| 2023 Q1 | -7.93 Million CAD | 21.34% |
| 2022 Q2 | -11.78 Million CAD | -11.69% |
| 2022 Q1 | -10.55 Million CAD | -69.36% |
| 2022 FY | -50.33 Million CAD | -10.7% |
| 2022 Q4 | -10.09 Million CAD | 43.67% |
| 2022 Q3 | -17.91 Million CAD | -52.03% |
| 2021 Q1 | -8.98 Million CAD | 6.64% |
| 2021 Q2 | -6.42 Million CAD | 28.47% |
| 2021 Q3 | -10.16 Million CAD | -58.23% |
| 2021 Q4 | -6.22 Million CAD | 38.71% |
| 2021 FY | -45.47 Million CAD | -120.67% |
| 2020 FY | -20.6 Million CAD | -51.7% |
| 2020 Q4 | -9.61 Million CAD | -118.07% |
| 2020 Q3 | -4.41 Million CAD | -23.07% |
| 2020 Q2 | -3.58 Million CAD | -16.48% |
| 2020 Q1 | -3.07 Million CAD | 6.51% |
| 2019 Q1 | -3.49 Million CAD | -6.88% |
| 2019 FY | -13.58 Million CAD | -81.27% |
| 2019 Q2 | -3.75 Million CAD | -7.28% |
| 2019 Q4 | -3.29 Million CAD | 8.17% |
| 2019 Q3 | -3.58 Million CAD | 4.52% |
| 2018 Q4 | -3.27 Million CAD | -34.4% |
| 2018 Q1 | -534.73 Thousand CAD | 6.39% |
| 2018 FY | -7.49 Million CAD | -369.7% |
| 2018 Q2 | -1.24 Million CAD | -133.69% |
| 2018 Q3 | -2.43 Million CAD | -94.92% |
| 2017 Q4 | -571.22 Thousand CAD | -12.59% |
| 2017 Q2 | -401 Thousand CAD | 0.0% |
| 2017 Q3 | -507.37 Thousand CAD | -26.52% |
| 2017 FY | -1.59 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -46.45 Million CAD | 35.88% |
| Avicanna Inc. | -7.93 Million CAD | -275.463% |
| Avant Brands Inc. | -1.45 Million CAD | -1952.757% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | -1422.776% |
| Knight Therapeutics Inc. | -2.89 Million CAD | -930.64% |
| MediPharm Labs Corp. | -18.25 Million CAD | -63.19% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 87.729% |
| Canopy Growth Corporation | -228.71 Million CAD | 86.977% |
| Willow Biosciences Inc. | -13.18 Million CAD | -125.956% |
| Auxly Cannabis Group Inc. | -19 Million CAD | -56.725% |